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Agnieszka Rak-Mardyła*, Martyna Durak and Ewa Łucja GregoraszczukAbstract
Background: Resistin was first reported to be an adipocyte-specific hormone, but recent studies have indicated a
connection between resistin and reproductive function. However, it is not yet known if resistin is expressed by the
ovary and if it can affect steroidogenesis in ovarian follicles from prepubertal pigs.
Methods: In this study, using real time PCR, immunoblotting, and ELISA, we quantified resistin expression and
concentration in maturing ovarian follicles (small, 3–4 mm; medium, 4–5 mm; large, 6–7 mm) collected from
prepubertal pigs. In addition, the dose-responsive effects of recombinant human resistin (0.1, 1, 10, and 100 ng/ml)
on steroid hormone (i.e., progesterone [P4], androstendione [A4], testosterone [T], and estradiol [E2]) secretion in
culture medium and steroidogenic enzyme (i.e., CYP11A1, 3betaHSD, CYP17A1, 17betaHSD, and CYP19A1)
expression in ovarian follicles were determined.
Results: We observed that resistin gene and protein expression increased significantly (P < 0.05) during follicular
growth, with large follicles expressing the highest level of this adipokine. Recombinant resistin also increased P4,
A4, and T secretion by up-regulating the steady state levels of CYP11A1, 3betaHSD, CYP17A1, and 17betaHSD.
Recombinant resistin had no effects on E2 secretion and CYP19A1 expression in ovarian follicles.
Conclusion: Our results show resistin expression in ovarian follicles from prepubertal pigs for the first time. We also
show that recombinant resistin stimulates steroidogenesis in ovarian follicles by increasing the expression of
CYP11A1, 3betaHSD, CYP17A1, and 17betaHSD. The presence of resistin in the porcine ovary and its direct effects
on steroidogenesis suggest that resistin is a new regulator of ovary function in prepubertal animals.
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Adipose tissue is known to control many cellular events
via endocrine, paracrine, or autocrine mechanisms.
Adipose tissue is rich in adipokines, secreted cytokines,
and hormones that participate in several physiological
and pathological processes such as food intake and
metabolic control, diabetes, atherosclerosis, immunity,
and reproductive function [1-3]. Leptin, adiponectin,
and resistin are three well studied adipokines. Of these,
resistin is a cysteine-rich C-terminal domain protein
belonging to the resistin-like molecule (RELM) family* Correspondence: agnieszka.rak@uj.edu.pl
Department of Physiology and Toxicology of Reproduction, Institute of
Zoology, Jagiellonian University in Cracow, Gronostajowa 9, Cracow 30-387,
Poland
© 2013 Rak-Mardyła et al.; licensee BioMed Ce
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium[4]. In humans, resistin is expressed largely by adipocytes
[5], and its serum level is elevated in morbidly obese
individuals [6]. While the role of resistin in energy
homeostasis is still unclear, previous studies have shown
it to exhibit changes in expression that are similar to
those of leptin [7,8]. For instance, fasting reduced both
resistin and leptin levels, and feeding resulted in their
concomitant increase [4,8]. Other studies have suggested
a connection amongst resistin, obesity, and insulin
resistance [9,10], illustrating the importance of adipokines
in mammalian physiology.
In recent studies, many investigators have linked
resistin to reproductive function. Nogueiras et al. [11]
showed resistin to increase both basal and human
chorionic gonadotropin (hCG)-stimulated testosteronentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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in vitro. They also demonstrated resistin expression in
the testis to be regulated by luteinizing hormone (LH)
and follicle stimulating hormone (FSH), two pituitary
hormones. In female rats, resistin expression was up-
regulated in adipose tissue from pubertal animals [12].
Interestingly, resistin expression in the pituitary gland
was found to be regulated by nutritional-, age-, and
gender-specific factors, and its expression was highest in
the pituitary gland of prepubertal mice [13]. Further-
more, resistin expression in adipocytes was 2-fold higher
in women with polycystic ovarian syndrome (PCOS)
than in healthy women [14]. Dafopoulus et al. [15] also
demonstrated that serum resistin levels remained
unchanged in normal cycling women, illustrating that
resistin secretion from adipocytes is unaffected by
fluctuations in sex steroid levels.
Recently, some data have suggested that resistin could
effect on ovary function. Maillard et al. [16] demon-
strated resistin expression in bovine and rat ovaries, and
showed that resistin modulate granulosa cells function
such as steroidogenesis and proliferation, in basal state
or in response to IGF-I in vitro. This is in agreement
with a study by Jones et al. [17], which reported resistin
expression throughout the rat estrous cycle. Study Spicer
et al. [18] showed that resistin inhibits steroidogenesis of
undifferentiated (small follicles) granulosa cells and
inhibits mitogenesis of differentiated (large follicles) gra-
nulosa cells collected from cattle. In human cultured theca
cells, recombinant resistin triggered 17α-hydroxylase
activity, a marker of ovarian hyperandrogenism in women
with PCOS [19].
Considering data of Morash et al., 2002 [13] showing
increasing resistin mRNA expression in pituitary of
prepubertal mice and their suggestions that resistin
could have functional implications during prepubertal
time we hypothesis that resistin could be important local
modulator of ovarian function during prepubertal time.
To our knowledge, there is no study reporting the
expression of resistin in ovarian follicles from prepubertal
pigs or the effects of resistin on ovarian steroidogenesis.
In the present study, we 1) investigate steady state resistin
expression and protein levels in developing ovarian folli-
cles collected from prepubertal pigs, 2) quantify resistin
concentrations in these ovarian tissues, and 3) study
the effects of recombinant human resistin on ovarian
steroidogenesis by investigating the levels of different




M199 medium and phosphate buffered saline (PBS) were
purchased from CytoGen, Poland. Antibiotic antimycoticsolution (100×), fetal bovine serum (FBS, heat inac-
tivated), TRIS, sodium deoxycholate, Nonidet NP-40,
sodium dodecyl sulfate (SDS), protease inhibitor (EDTA-
free), dithiothreitol (DTT), Tween 20, and bromophenol
blue were obtained from Sigma-Aldrich (St. Louis, MO,
USA). Recombinant human resistin was obtained from
Phoenix Pharmaceuticals, Inc. (Burlingame, CA, USA).
Human resistin was utilized in this experiment because
porcine resistin was not readily available at the onset of
the experiment. Human resistin differs from porcine
resistin only by one amino acids [20].
Sample collection
Porcine ovaries were collected from prepubertal (4–
5 months of age) crossbred gilts (Large White and Polish
Landrace) at a local abattoir. Approximately 15 min
elapsed from slaughter to ovary collection. Small (SF,
3–4 mm; n = 6), medium (MF, 4–5 mm; n = 6) and large
(LF, 6–7 mm; n = 6) follicles were obtained from
animals, as described previously [21]. For each experi-
ment described below, six ovaries from three different
animals were selected. Since each ovary yielded four to
six follicles, the total number of follicles for each prepa-
ration varied between 24 and 36. This approach was
used to minimize experimental variation throughout the
study. Follicular fluid was also aspirated from follicles
using a sterile needle and syringe.
Experimental procedure
In Experiment 1 analysis of resistin gene expression in
ovarian follicles was determined. For RNA isolation,
whole ovarian follicles after excision of ovary and follicu-
lar fluid collected, were immediately frozen in liquid ni-
trogen and then stored at -70°C.
Experiment 2 quantified resistin expression in whole
ovarian follicles, and determined resistin concentrations
protein in follicular fluid. SFs, MFs, and LFs were
homogenized twice in ice-cold lysis buffer (50 mM
Tris–HCl (pH 7.5) at 22°C containing 100 mM NaCl,
0.5% sodium deoxycholate [wt/vol], 0.5% NP-40 [vol/vol],
0.5% SDS [wt/vol], and protease inhibitor). Lysates were
cleared by centrifugation at 15,000 × g at 4°C for 30 min,
and protein content was determined by a protein assay
(Bio-Rad Laboratories, Munchen, Germany) using bovine
serum albumin (BSA) as a standard. All samples were
stored at −20°C until further analysis.
Experiment 3 investigated the short-term effects of re-
combinant human resistin on steroid hormone (i.e., P4,
A4, T, and E2) secretion and steroidogenic enzyme (i.e.,
CYP11A1, 3βHSD, CYP17A1, 17βHSD, and CYP19A1)
expression. After isolation, follicles were cut, using small
scissors, to facilitate penetration of the compounds into
the tissue and removal oocytes and follicular fluids.
Whole ovarian follicles, including theca and granulosa
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cultured in 24-well plates with M199 medium sup-
plemented with 5% FBS [vol/vol] and increasing concen-
trations of resistin (0.1, 1, 10, and 100 ng/ml) at 37°C in
a humidified atmosphere containing 5% CO2 [vol/vol].
These doses were chosen based on a previously
published study [12] and on Experiment 2. After 24 h,
conditioned culture media were collected and stored at
−20°C for steroid hormone determination. Cultured
ovarian follicles was homogenized twice in ice-cold lysis
buffer and centrifuged at 15,000 × g at 4°C for 30 min.
Protein content was determined as described above. All
samples were stored at −20°C until further analysis. It
should be noted that this in vitro model was previously
used to study the function of leptin in the porcine ovary
[22]. Based on our experience, this model mimics ovar-
ian physiology more closely than co-cultures of different
ovarian cells or cell lines.
Experiment 4 examined the short-term effects of
recombinant resistin on steroidogenic enzyme (i.e.,
CYP11A1, HSD3B1 [3βHSD], CYP17A1, HSD17B1
[17βHSD], and CYP19A1) mRNA expression. This ex-
periment was similar to Experiment 3, except that cul-
tured ovarian follicles was frozen immediately in liquid
nitrogen and then stored at −70°C for RNA isolation.
Total RNA isolation and cDNA synthesis
Isolation of total RNA, including a 15 min treatment
with DNase I, was carried out with the High Pure
RNA Tissue kit (Roche Applied Science, Mannheim,
Germany). RNA concentrations were determined by
spectrophotometry at 260 and 280 nm (BioPhotometer
Plus, Eppendorf, Germany), and 1 μg of RNA was used
for reverse transcription. Reverse transcription was
performed using the Transcriptor First Strand cDNA
Synthesis kit (Roche Applied Science) in combination
with 50 pmol/μL anchored-oligo(dT)18 primer and 600
pmol/μL random hexamer primers. The reverse
transcription reaction was incubated at 25°C for 10 min.
This was followed by two subsequent incubations at
50°C for 60 min and 85°C for 5 min, and then cooling to
4°C. Samples were stored at −20°C until further analysis.Table 1 Characteristic of investigated gens
Gene symbol Gene name
RETN resistin
CYP11A1 cytochrome P450, family 11, subfamily A, polypeptide
HSD3B1 (3βHSD) hydroxy-delta-5-steroid dehydrogenase, 3 beta- and s
CYP17A1 (CYP17) cytochrome P450 17A1
HSD17B1 (17βHSD) hydroxysteroid (17-beta) dehydrogenase 1
CYP19A1 (CYP19) cytochrome P450 19A1
GAPDH glyceraldehyde-3-phosphate dehydrogenase
TaqMan gene expression assays were used to quantify mRNA expression.Real time PCR
Real time PCR analyses were performed using either
StepOne Real-Time PCR (Applied Biosystems, Carlsbad,
CA, USA) or LightCycler®Nano SW1.0 Real-Time PCR
(Roche Diagnostics, Indianapolis, IN, USA) systems.
TaqMan Gene Expression assays were used to quantify
mRNA expression (Table 1). GAPDH was used as an
internal control. Quantitative PCR was performed with
100 ng cDNA, 1 μL TaqMan Gene Expression primers,
and 10 μL TaqMan PCR master mix (Applied Biosystems)
in a final reaction volume of 20 μL. After a 2 min incuba-
tion at 50°C, thermal cycling conditions were 10 min at
95°C, followed by 40 cycles of 15 sec at 95°C and 1 min at
60°C to determine the cycle threshold number (Ct) for
quantitative measurement. Data were analyzed using the
comparative threshold cycle (Ct) method and expressed as
a ratio of target gene to GAPDH.Immunoblot analysis
Immunoblotting was performed as previously described
[21]. Briefly, equal amounts of lysate (~30–50 μg protein/
lane) were separated on 10–15%T SDS-polyacrylamide
gels. Separated proteins were transferred onto nitrocellu-
lose membranes and blocked with 5% non-fat dry milk in
Tris-buffered saline containing 0.1% Tween-20 [vol/vol]
(TBS-T). Membranes were then incubated overnight at
4°C with anti-resistin (cat. #sc-17575), anti-CYP11A1 (cat.
#sc-18040), anti-3βHSD (cat. #sc-30820), anti-CYP17A1
(cat. #sc-46084), anti-17βHSD (cat. #sc-26963), or anti-
CYP19A1 (cat. #sc-14244) antibodies (1:200, Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA) on a shaker.
After washing with TBS-T, membranes were incubated
with a horseradish peroxidase-conjugated secondary anti-
body (Santa Cruz Biotechnology, Inc.). Immune com-
plexes were detected by chemiluminescence (ECL) using
Western Blotting Luminol reagent (Santa Cruz Biotech-
nology, Inc.) and visualized with a Chemidoc™ XRS+
system (Bio-Rad Laboratories). Proteins of interest were
quantified using Image Lab™ 2.0 software (Bio-Rad
Laboratories). An anti-β-actin antibody (1:3000) was used
as a loading control (Cat. #A5316, Sigma-Aldrich).Catalog number Reference sequence
Ss03381389_u1 NM_213783.1
1 Ss03384849_u1 NM_214427.1
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A commercially available human resistin enzyme-linked
immunosorbent assay (ELISA) (cat. # EIA-4945, DRG
International, Inc., Mountainside, NJ, USA) was used to
quantify resistin concentrations in ovarian follicles
lysates and follicular fluid. Samples were run in triplicate
within the same assay. The sensitivity of the resistin
assay was 0.016–1 ng/ml, and the intra- and inter-
experimental coefficients of variation were 10% and 15%,
respectively.
Hormone ELISAs
Steroid hormone (i.e., P4, A4, T, and E2) levels were
determined in conditioned culture media using commer-
cially available ELISA kits (cat. #s EIA-1561, EIA-3265,
EIA-1559, and EIA-2693, DRG Diagnostic, Marburg,
Germany). E2 levels were also measured in follicular
fluid, and samples were run in duplicate within this
assay. The sensitivity of each assay was 0.045 ng/ml for
P4, 0.019–10 ng/ml for A4, 0.083–16 ng/ml for T, and
9.7–2000 pg/ml for E2. The intra- and inter-experimental
coefficients of variation were 6.99% and 4.34% for P4,
5.6% and 12.1% for A4, 3.28% and 6.71% for T, and 2.71%
and 6.72% for E2, respectively. Cross-reactivity between T
and A4 was 0.9%, and between T and E2 was <0.1%.
Cross-reactivity amongst E2, A4, and T was 0%, but cross-
reactivity with estrone was 0.2% based on specification
sheets provided by the manufacturer. All other samples
were run in quadruplicate within each assay.
Statistical analysis
Real time PCR, Western blot and ELISA experiments
were performed three independent times. In each ex-
periment six ovaries from three different animals were
selected. Data were plotted as mean ± S.E.M. All re-
maining data were shown as the mean ± S.D. Statistical
analyses were performed using GraphPad Prism 5 soft-
ware (La Jolla, CA, USA). Data were analyzed using a
one-way analysis of variance (ANOVA) test, followed by
Tukey’s honestly significant difference (HSD) test.
Statistical significance is indicated by different letters
or * P < 0.05.
Results
Resistin expression and concentration in ovarian follicles
Real time PCR experiments showed that ovarian follicles
obtained from prepubertal pigs expressed resistin.
Resistin expression in ovarian follicles increased signifi-
cantly with follicular growth, with LFs expressing the
highest level of this adipokine (1.5-fold increase com-
pared to SFs and 1.2-fold increase compared to MFs,
P < 0.05) (Figure 1).
To confirm real time PCR results, immunoblotting
was performed using SF, MF, and LF lysates andfollicular fluid. The steady state level of resistin in-
creased significantly in maturing follicles as well as in
follicular fluid (Figure 1B). In agreement with the data
shown in Figure 1A, resistin was highest in both LF
lysate and follicular fluid (2-fold for SFs and 1.8-fold
for MFs in follicular fluid, and 1.8 fold to SFs and 1.6
fold to MFs in ovarian follicles tissue) (P < 0.05). For
positive control we used porcine white adipose tissue
(Figure 1C).
Resistin levels were higher in SFs (0.27 ng/μg protein),
MFs (0.29 ng/μl protein), and LFs (0.411 ng/μg protein)
than in follicular fluid collected from corresponding fol-
licles (0.03, 0.03, and 0.106 ng/μg protein, respectively)
(Figure 1D, P < 0.05). The increase in resistin during fol-
licular growth also correlated with a steady increase in
estradiol in follicular fluid collected from SFs, MFs, and
LFs (3.87, 7.22, and 9.58 pg/ml, respectively) (Figure 1E).
Effects of resistin on the secretion of steroid hormones
Basal steroid secretion in conditioned culture media col-
lected from SFs was 6.2 ng/ml for P4, 3.3 ng/ml for A4,
7.5 ng/ml for T, and 8.7 ng/ml for E2. Recombinant
resistin at increasing concentrations stimulated P4 (8.9,
9.2, 8, and 7.6 ng/ml at 0.1, 1, 10, and 100 ng/ml doses
of resistin, respectively) and T (10.9, 11.9, 9.8, and
10.7 ng/ml at 0.1, 1, 10 and 100 ng/ml doses of resistin,
respectively) secretion. Both A4 and E2 in SF condi-
tioned culture media remained unchanged by recombin-
ant resistin (Figure 2A, P < 0.05).
Basal steroid secretion in MF conditioned culture
media was 8.7 ng/ml for P4, 2.7 ng/ml for A4, 8.6 ng/ml
for T, and 9.5 ng/ml for E2. Recombinant resistin at in-
creasing concentrations stimulated P4 (10.1, 11.8, and
11.8 ng/ml, respectively), A4 (3.9, 4.2, and 5.9 ng/ml, re-
spectively), and T (10.8, 13.7, 13.6, and 11.4 ng/ml, re-
spectively) secretion. Recombinant resistin had no effect
on E2 secretion (Figure 2B; P < 0.05).
Finally, basal steroid secretion in LF conditioned cul-
ture media was 10.8 ng/ml for P4, 3.1 ng/ml for A4,
13.1 ng/ml for T, and 11.4 ng/ml for E2. Recombinant
resistin at increasing concentrations up-regulated P4
(12.2, 11.7, and 12.8 ng/ml, respectively), A4 (4, 4.5, 4.3,
and 4.3 ng/ml, respectively), and T (14.3, 14.1, 14.8, and
15.9 ng/ml, respectively) secretion. Likewise, E2 secre-
tion remained unchanged by recombinant resistin in LF
conditioned culture media (Figure 2C, P < 0.05).
Effects of recombinant human resistin on the mRNA
expression of steroidogenic enzymes
To investigate the effects of increasing concentrations of
recombinant resistin (0.1, 1, 10, and 100 ng/ml) on
steroidogenic enzyme mRNA expression, real time
PCR was performed on total RNAs isolated from SFs,
MFs, and LFs. The expression of each gene (i.e.,
Figure 1 Resistin expression and concentration in ovarian follicles. Resistin expression and concentration in ovarian follicles collected from
prepubertal animals; A) The ratio of resistin gene intensity to GAPDH intensity was used to represent the abundance of resistin mRNA in the
ovarian follicles. B) The amount of protein (50 μg) in every sample was checked by immunoblot using anti-β-actin antibody. Upper panels:
representative blots of tissue homogenates resolved by 15% SDS–PAGE, immunoblotted with resistin antibodies and reprobed with β-actin
antiserum. Lower panels: results of densitometric quantification of bands. The data are expressed as the mean±SEM of rations relative to GAPDH
or to β-actin. C) For positive control we used porcine white adipose tissue. D) Concentrations of resistin in follicular fluid and ovarian tissue.
Different letters indicate statistically significant differences among groups (P < 0.05). E) Estradiol concentrations in follicular fluid.
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was normalized to the expression of GAPDH. Recom-
binant resistin at all investigated doses stimulated
significantly CYP11A1 and 3βHSD expression in SFs
(P < 0.05). Resistin at 1, 10, and 100 ng/ml also in-
creased 17βHSD expression in SFs, but no significant
changes in expression were observed for CYP17A1
and CYP19 (Figure 3A).
Likewise, the expression of CYP11A1 (at 0.1, 1, 10, and
100 ng/ml of resistin), 3βHSD (at 0.1, 1, and 10 ng/ml of
resistin), CYP17A1 (at 0.1, 1, 10, and 100 ng/ml of
resistin), and 17βHSD (at 1, 10, and 100 ng/ml of
resistin) increased significantly in MFs after the addition
of recombinant resistin (Figure 3B, P < 0.05). Recombin-
ant resistin had no effect on CYP19 expression.
Recombinant resistin also up-regulated the expression
of CYP11A1 (at 0.1, 1, 10, and 100 ng/ml of resistin),
3βHSD (at 1, 10, and 100 ng/ml of resistin), CYP17A1
(at 100 ng/ml of resistin), and 17βHSD (at 0.1, 1, 10, and
100 ng/ml of resistin) in LFs (Figure 3C, P < 0.05);however, CYP19 expression in LFs remained unchanged
by recombinant resistin.
Effects of recombinant human resistin on the protein
expression of steroidogenic enzymes
The steady state levels of CYP11A1, 3βHSD, CYP17A1,
17βHSD, and CYP19 were investigated in developing
ovarian follicles incubated with recombinant resistin,
and representative immunoblots from this experiment
are shown in Figure 4. Proteins were densitometrically
scanned and normalized against β-actin (Figure 5).
Resistin at different concentrations up-regulated the
expression of CYP11A1, 3βHSD, and 17βHSD in SFs
(Figure 5A, P < 0.05).
Resistin at increasing concentrations also stimulated
CYP11A1, 3βHSD, CYP17A1, and 17βHSD in MFs
(Figure 5B, P < 0.05).
Significant differences were also observed in the steady
state levels of CYP11A1, 3βHSD, CYP17A1, and
17βHSD following incubation of LFs with increasing
Figure 2 Effects of recombinant human resistin (0.1, 1, 10, and
100 ng/ml) on steroid hormone (i.e., progesterone [P4],
androstendione [A4], testosterone [T], and estradiol [E2]) secretion
in culture medium from A) small, B) medium and C) large ovarian
follicles. ELISA experiments were performed three independent
times. In each experiment six ovaries from three different animals
were selected. Data were plotted as mean±S.E.M. Different letters
indicate statistically significant differences among groups (P < 0.05).
Figure 3 Effects of recombinant human resistin (0.1, 1, 10, and
100 ng/ml) on the mRNA expression of steroidogenic enzymes
(i.e., CYP11A1, 3βHSD, CYP17A1, 17βHSD, and CYP19A1) in A)
small, B) medium and C) large ovarian follicles. The expression
of mRNA has been determined by real time-PCR. The expression of
each gene was normalized to the expression of GAPDH. Real time PCR
experiments were performed three independent times. In each
experiment six ovaries from three different animals were selected. Data
were plotted as mean±S.E.M. Statistical significance is indicated by *
P< 0.05.
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unchanged by recombinant resistin (Figure 5C).
Discussion
Female puberty, the estrous cycle, and reproduction are
known to be regulated by the hypothalamic-pituitary
axis which is comprised of many critical hormones.
Many studies have shown that locally produced factors
such as steroids, growth factors, and peptides regulatethe development of ovarian follicles and the onset of
puberty and/or ovulation [23]. Other studies have
reported the expression of leptin, an adipose tissue
hormone, in the ovary [24], where it was found to regu-
late ovarian function during puberty [25] and the estrous
cycle in humans, mice, rats, pigs, and cows [26-28].
Unfortunately, the role of resistin in ovarian follicle
development is currently unknown. The present study
Small follicles Medium follicles Large follicles
resistin (ng/ml) C 0.1 1 10 100 C 0.1 1 10 100 C 0.1 1 10 100
CYP11A1
β-actin
* * * * * *
3βHSD
β-actin
* * * * * * * * *
CYP17A1
β-actin
* * * * *
17βHSD
β-actin
* * * * * * * *
CYP19
β-actin
Figure 4 Effects of recombinant human resistin. (0.1, 1, 10, and 100 ng/ml) on the protein expression of steroidogenic enzymes
CYP11A1, 3βHSD, CYP17A1, 17βHSD, and CYP19 small, medium and large ovarian follicles. The representative samples of western blots
are shown in the panels. Western blot experiments were repeated three independent times using samples from three different animals. Data
were plotted as mean±S.E.M. Statistical significance is indicated by * P < 0.05.
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porcine prepubertal ovarian follicles. Using real time
PCR, Western blot, and ELISA, we show differences in
the expression and concentration of resistin in follicular
fluid collected from SFs, MFs, and LFs. In ovarian
follicles collected from prepubertal animals, a ~1.6-fold
increase in expression and a ~2-fold increase in protein
were observed in LFs, correlating with resistin levels in
follicular fluid and follicular tissue. Our results show that
resistin expression in the prepubertal ovary also correlated
with an increase in estradiol in follicular fluid. Puberty is
characterized by increasing concentrations of estradiol,
driven by increasing concentrations of pituitary gonado-
tropins which are, in turn, regulated by gonadotropin-
releasing hormone that is released by hypothalamic
neurons [29]. Chen et al. [30] used 3 T3-L1 adipocytes to
show that estradiol stimulates resistin expression in a
dose- and time-dependent manner. This is in agreement
with other studies that showed androgens [31] and growth
hormones [32] to increase during puberty, and to stimu-
late the expression of resistin. Additionally, a strong link
between resistin and development has been found in rats,
where resistin expression was highest at puberty only to
decrease in adipose tissue [12]. Moreover, Li et al. [33]
showed human resistin levels to decrease with age and
puberty in both genders.
In agreement with our results, Maillard et al. [16]
showed resistin expression in the bovine and rat ovary.
For instance, they demonstrated resistin to be widely
expressed in SFs (<6 mm) and LFs (>6 mm), corpora
lutea, and oocytes as well as in cumulus, theca, and
granulosa cells. Interestingly, resistin expression was
approximately 5-fold higher in freshly isolated granulosa
cells than in cells that were cultured in vitro. Within theovary, resistin expression was detected in the corpus
luteum, oocyte, theca, and granulosa cells [16]. Jones et al.
[17] also showed resistin expression in the rat ovary. In an
earlier study, Dai et al. [34] cloned and characterized
porcine resistin, and they found serum resistin to circulate
as a dimer and a trimer and they also suggest that pig may
be a suitable animal model for studying the function of
resistin in human insulin resistance [34].
The in vitro effects of recombinant resistin on steroid
hormone secretion and steroid enzyme expression were
also interesting as they may represent a unique mechan-
ism of resistin action in the prepubertal ovary. Our
results showed that recombinant resistin increased P4,
A4, and T secretion in conditioned culture media from
MFs and LFs; however, E2 secretion was unaffected.
These results were confirmed by additional experiments
that showed recombinant resistin to affect the steady
state levels of CYP11A1, 3βHSD, CYP17A1, and
17βHSD. These findings are also consistent with a previ-
ous in vitro study by Munir et al. [19] that showed
resistin to increase androgen production in cultured
human theca interna tissue from small antral follicles
(8–9 mm) normal cycling premenopausal women. They
also observed that resistin (1 ng/ml) or a combination of
resistin, forskolin, and insulin, enhanced CYP17 expres-
sion and 17α-hydroxylase activity (a marker of ovarian
hyperandrogenism in PCOS women) [19]. In our study
we used porcine whole ovarian follicles collected from
prepubertal animals. Prenatal, perinatal, or postnatal
height androgen exposure in many species such as in
monkeys [35], sheep [36], rats [37], and mice [38] can
induce many symptoms characteristic of PCOS. Never-
theless, data on the effects of resistin on ovarian ste-
roidogenesis are contradictory. In cultured rat granulosa
Figure 5 Densitometric analysis of the protein levels of
steroidogenic enzymes CYP11A1, 3βHSD, CYP17A1, 17βHSD,
and CYP19 in A) small, B) medium and C) large ovarian
follicles. Proteins were densitometrically scanned and normalized
against β-actin. Western blot experiments were repeated three
independent times using samples from three different animals.
Data were plotted as mean±S.E.M. Statistical significance is indicated
by * P < 0.05.
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http://www.rbej.com/content/11/1/45cells, P4 secretion increased following treatment with a
physiological dose of resistin (10 ng/ml) with no effects on
E2, while resistin decreased both P4 and E2 production by
granulosa cells isolated from the cow ovary [16]. These
contradictory findings led the authors to conclude that
resistin is regulated differently across species [16]. Further-
more, Spicer et al. [18] showed that resistin inhibited ste-
roidogenesis in theca and granulosa cells from small
(1–5 mm) and large (8–22 mm) cattle follicles.Taken collectively, our data showed that resistin
expression increased during follicular development. We
also showed that recombinant resistin stimulated andro-
gen secretion from ovarian follicles by up-regulating the
steady state levels of CYP11A1, 3βHSD, CYP17A1, and
17βHSD. Lastly, recombinant resistin had no effects on
E2 secretion and CYP19A1 expression in porcine
prepubertal ovarian follicles.
Conclusion
In this study, we demonstrated resistin expression in
ovarian follicles obtained from prepubertal pigs. This
expression increased during follicular development, with
LFs expressing the highest level of the adipokine. We
also demonstrated that recombinant resistin affected
ovarian steroidogenesis by stimulating androgen produc-
tion and steroid enzyme expression. In conclusion, the
presence of resistin in the porcine ovary and its direct
effects on steroidogenesis suggest that resistin may be a
new regulator of ovary function in prepubertal animals.
However, additional studies on in vivo model are neces-
sary to confirm this hypothesis.
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